Albany Molecular Research, Inc. (AMRI) Promotes Daniel Conlon to Senior Director of Business Development
Published: Sep 10, 2012
ALBANY, N.Y., Sept. 10, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Daniel Conlon has been promoted to Senior Director, Business Development, AMRI, reporting to Christopher Conway, Vice President, Business Development, North America.
In this newly created role, Conlon will lead AMRI's development and manufacturing services sales team for North America. His responsibilities will include assisting with the strategic direction for generating sales in the North American territory and with the execution of revenue goals for his team.
"Dan is a leader in the truest sense of the word," Mr. Conway says. "He has the proven ability to energize a team while setting the highest attainable standards. Dan's sales and management experience makes him ideal for this position."
Conlon's demonstrated knowledge and ability to sell AMRI's development and manufacturing services earned him the top sales position in 2012. Before joining AMRI in 2010, Conlon held a sales and management position with Merck, formally Organon BioSciences. He worked for Merck/Organon for eight years starting as a Sales Representative/District Trainer. Following this role, he was promoted to District Sales Manager overseeing a team across multistate districts.
"The strengthening of our Business Development team will help us build upon an already solid foundation for growth and will further enhance AMRI's strategic SMARTSOURCING approach," said Thomas D'Ambra, Ph.D., AMRI's Chairman, President and Chief Executive Officer. "We are very encouraged by the talented and motivated people on our team, and the prospects for continued growth in the future."
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For press releases and additional information about the company, please visit www.amriglobal.com.